Introduction
The bacteria Clostridioides difficile (C. diff) is a significant health threat which can lead to diarrhea, colitis, and even death. In 2017, C. diff caused nearly half a million infections among people in the United States, more than 100,000 of whom were residents in LTC facilities. 1 Many risk factors contribute to the development of C. diff infection, including an age of 65 years and older, a weakened immune system, a history of previous C. diff infection, and recent hospitalization. 2 Medications that suppress gastric acid production are also contributory factors. 3 A significant risk factor for developing C. diff infection is antibiotic use. Antibiotics can result in weeks to months of suppression of gut microbiota bacteria that defend against infection. When "good" gut bacteria are suppressed, there is an increased risk of becoming infected from ingesting the C. diff spore through contact with another person or a contaminated surface. 1 Residents of LTC facilities are at increased risk for developing a C. diff infection. For this reason, they may also be subject to overtesting. Testing for C. diff outside of the recommended guidelines-such as testing of asymptomatic residents-can result in overdiagnosis and overtreatment. Inappropriate testing can lead to increased costs and implications for residents stemming from contact isolation and unnecessary antibiotics. 4 In 2010, a joint expert panel appointed by the Infectious Diseases Society of America (IDSA) and the Society for Healthcare Epidemiology of America (SHEA) provided guidelines 6 to improve the diagnosis and management of C. diff infection in adults. In 2017, IDSA and SHEA issued updated guidelines 7 containing significant changes in the recommended management of C. diff infection and best practices for diagnosis.
Challenges Facing LTC Facilities
In recent months, infection prevention experts at the Patient Safety Authority (PSA) have received many questions from infection prevention designees and other leaders from Pennsylvania long-term care facilities related to C. diff testing. These questions concern whether residents should be screened for C. diff on admission to rule out infection, if a specimen should be sent at the first sign of a liquid stool to rule out C. diff, and the nature of the difference between colonization and active infection. In light of the questions and subsequent conversations with facility representatives, there appears to be a knowledge deficit regarding the IDSA and SHEA guidelines. 
Disclaimer
Sherry's story is a composite of cases from the authors' professional nursing experiences. Adverse outcomes were fictionalized according to research related to the implications of contact isolation, and Sherry, Donna, and the nursing facility Cedar Springs are fictitious.
The algorithm depicted in Figure 1 is based on Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)7; however, the algorithm does not reflect these guidelines verbatim. 7 Testing and Treatment Implications While antibiotic therapy and contact precautions are indicated for active C. diff infection, asymptomatic colonization of C. diff does not require treatment. The adverse effects of treatment and isolation can harm residents who are tested outside the recommended guidelines. Antibiotics can disrupt the normal bacterial flora of the intestine. Normal bacterial flora is important, as it assists with the breakdown and absorption of food nutrients, metabolizes medication, and protects against harmful bacteria. 4 Oral vancomycin, often used in treating C. diff, may allow production of vancomycin-resistant enterococci (VRE), 5 which can make future treatment difficult. Contact precautions, which are intended to prevent and reduce transmission of organisms throughout the facility and from person to person, 8 can have a negative impact on facilities and residents.
Contact precautions can be costly for LTC facilities. They require personal protective equipment-e.g., gown and gloves-each time someone enters the room. This results in direct costs for the materials, as well as labor time for healthcare workers donning and doffing their gear. 9 Additional costs are associated with a private room, including the inability to place another resident not infected with C. diff in the same room. If an isolation room or private room is not available, a resident may need to be transferred to another facility.
Contact precautions also can have detrimental effects on residents. In their systematic review of the literature based on research performed in inpatient settings, 10 Morgan and colleagues identified many adverse outcomes related to contact precautions, including a twofold increase in falls, pressure injuries, and fluid and electrolyte imbalances. Contact precautions were associated with fewer residenthealthcare worker interactions and fewer visits from friends and family members. Isolated residents were more likely to feel bored and socially isolated, resulting in depression, anxiety, and anger. In another study, 11 the observations of healthcare workers made during contact precautions in skilled nursing facilities identified potentially harmful consequences, such as confusion, depression, and a decrease in self-esteem.
Avoiding Overtesting
Asymptomatic C. diff colonization is common among residents of LTC facilities. 12 Therefore, it is imperative that testing be performed in accordance with recommended guidelines to avoid overdiagnosis and overtreatment. Recent studies have shown that mindful application of testing guidelines can save money, prevent overtesting, and decrease C. diff infections. [13] [14] Parada and colleagues conducted a study to review C. diff order appropriateness. The study was conducted during a six-month trial by a 10-person team, based on an algorithm guideline for testing. Review of 678 C. diff orders showed that 428 (63.1%) were approved and 250 (36.9%) were rejected. A mandatory review was performed on all C. diff testing orders. Orders that correlated with the algorithm were approved. Orders that did not correlate with the algorithm were rejected and communicated to the care team. Appeals to the rejection of testing could be made on a case-by-case basis to the medical director of infection control. This study also included early identification of communityacquired C. diff to quickly initiate contact isolation and prevent diagnosis being classified as hospitalacquired. As a result of the study, the facility saved approximately $15,000 in laboratory testing costs, avoided overdiagnosing colonized patients as having C. diff infection, and achieved a significant drop in their infection numbers. 13 In another study, a hospital revised its in-house C. diff testing guidelines to correlate with the 2017 IDSA/SHEA guidelines. The facility changed documentation requirements to help providers test more appropriately, limited testing to patients with three or more unformed stools per day, and excluded testing within 24 hours of laxative use. The laboratory also rejected specimens sent within seven days of previous negative results. C. diff testing decreased by 47%, from 358 to 188 tests per month. The number of C. diff infections decreased by 39% in one year (from 141 to 83). The facility also targeted improvements in hand hygiene, antimicrobial stewardship, and cleaning and disinfection of the facility. By revising the guidelines and documentation requirements, C. diff cases and overdiagnosis decreased. 14 Although these studies were conducted in a hospital setting, similar outcomes may be achieved in LTC facilities by using an algorithm and testing in accordance with guidelines. 5. Use a supportive decision-making tool, such as the algorithm for appropriate testing of C. diff in Figure 1 , before collecting a specimen for C. diff.
Improving
6. If possible, develop a relationship with the laboratory to distinguish testing methods. Senior leadership may need to be involved in collaboration efforts. Develop a hardstop protocol to reject specimens that have been tested during the same episode of diarrhea (within seven days), and do not test stool from asymptomatic residents, except for epidemiological studies such as during an outbreak.
7. During the same episode of diarrhea, do not repeat testing (within seven days).
8
. Residents should not be tested to determine if their C. diff infection has been cured. Testing should only be performed as described above.
Reflection on the Bedside Story
Following Sherry's death, her family and friends were overcome with grief. They could not understand how someone who was once was so active and full of life could be gone so quickly.
Cedar Springs performed a root cause analysis related to Sherry's fall. During chart review, they discovered that Sherry did not meet the testing criteria of unexplained liquid stool (diarrhea) and new onset of three or more liquid stools in 24 hours-she had only one liquid stool in 24 hours. She also had laxative tablets that day, which may have contributed to the liquid stool. If the IDSA/SHEA clinical practice guidelines had been followed, Sherry's story could have ended very differently, with her returning home to enjoy retired life with her friends and family.
Conclusion
As illustrated by Sherry's case, the significant implications of unnecessary C. diff testing are avoidable. By using the algorithm for appropriate testing of C. diff and applying the strategies outlined in this article, LTC facilities can ensure C. diff testing is performed according to best practices, thereby avoiding unnecessary costs and, potentially, preventable adverse patient outcomes. 
